{"id":"W2066711959","doi":"10.1016/j.rmed.2015.02.005","title":"A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease","year":2015,"lang":"en","type":"article","venue":"Respiratory Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Crossover study; Agonist; Double blind; Anesthesia; Pharmacology; Internal medicine; Placebo; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009202966,0.000862915,0.001445084,0.0004138149,0.0004209433,0.00009096019,0.0004558348,0.0001895442,0.00009714709],"category_scores_gemma":[0.0004798451,0.0005067197,0.0002350559,0.0008227821,0.001242149,0.0004819005,0.0001730586,0.0007221547,0.00002158567],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004007033,"about_ca_system_score_gemma":0.00321112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004150532,"about_ca_topic_score_gemma":0.0005229497,"domain_scores_codex":[0.9942611,0.0002677613,0.0009888135,0.001314529,0.00184773,0.001320053],"domain_scores_gemma":[0.9952623,0.0008394389,0.0005884547,0.001225633,0.0007964359,0.001287753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8841238,0.001666881,0.1077454,0.0004540744,0.0006042445,0.0004519879,0.000571578,0.0002132737,0.00007890634,0.00002596468,0.0003052477,0.003758619],"study_design_scores_gemma":[0.8112687,0.01139408,0.1660515,0.0007297992,0.0009820317,0.0000199988,0.0008069724,0.001126508,0.00009964099,0.00001053478,0.007077211,0.0004330692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796946,0.002041979,0.0001912966,0.0005807573,0.0007040683,0.01459217,0.0001360542,0.0001143847,0.001944683],"genre_scores_gemma":[0.9928468,0.00001281062,0.0001280224,0.0001979099,0.001909094,0.003607386,0.0003797809,0.0001801415,0.0007380035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07285513,"threshold_uncertainty_score":0.9998164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1251470086507686,"score_gpt":0.345273865195002,"score_spread":0.2201268565442333,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}